Cervarix adverse reactions a hot topic in MHRA's latest safety update
This article was originally published in Scrip
Executive Summary
While the UK MHRAencourages people to report suspected adverse reactions to GlaxoSmithKline's Cervarix now that the routine immunisation programme for human papillomavirus has started, it advises that caution should be exercised in reporting reactions associated with the injection process.